نتایج جستجو برای: paclitaxel

تعداد نتایج: 16677  

Journal: :Carcinogenesis 2013
Niranjan Awasthi Changhua Zhang Anna M Schwarz Stefan Hinz Changguang Wang Noelle S Williams Margaret A Schwarz Roderich E Schwarz

Gemcitabine has limited clinical benefits in pancreatic ductal adenocarcinoma. The solvent-based traditional taxanes docetaxel and paclitaxel have not shown clinical results superior to gemcitabine. Nab-paclitaxel, a water-soluble albumin-bound paclitaxel, may carry superior distribution properties into the tumor microenvironment and has shown efficacy in multiple tumor types. We evaluated nab-...

Journal: :Annals of Oncology 2021

•The phase III IMpassion131 trial evaluated atezolizumab combined with paclitaxel as first-line therapy for aTNBC.•The primary endpoint was investigator-assessed PFS, tested hierarchically in the PD-L1+ and then ITT populations.•Neither PFS nor OS improved combination of plus either population.•These findings may result from imbalances prognostic features or chance a relatively small trial.•IMp...

2017
Yanfang Yang Hainan Zhao Roberto A. Barrero Baohong Zhang Guiling Sun Iain W. Wilson Fuliang Xie Kevin D. Walker Joshua W. Parks Robert Bruce Guangwu Guo Li Chen Yong Zhang Xin Huang Qi Tang Hongwei Liu Matthew I. Bellgard Angela Hoffman Jinsheng Lai Deyou Qiu Roberto A Barrero Iain W Wilson Kevin D Walker Joshua W Parks Matthew I Bellgard

Background: Paclitaxel (TaxolTM) is an important anticancer drug with a unique mode of action. The biosynthesis of paclitaxel had been considered restricted to the Taxus species until it was discovered in Taxomyces andreanae, an endophytic fungus of T. brevifolia. Subsequently, paclitaxel was found in hazel (Corylus avellana L.) and in several other endophytic fungi. The distribution of paclita...

2013
Seong Soo Choi Won Uk Koh Jae Sik Nam Jin Woo Shin Jeong Gill Leem Jeong Hun Suh

BACKGROUND Although paclitaxel is a widely used chemotherapeutic agent for the treatment of solid cancers, side effects such as neuropathic pain lead to poor compliance and discontinuation of the therapy. Ethyl pyruvate (EP) is known to have analgesic effects in several pain models and may inhibit apoptosis. The present study was designed to investigate the analgesic effects of EP on mechanical...

2015
Rishil J. Kathawala Liuya Wei Nagaraju Anreddy Kang Chen Atish Patel Saeed Alqahtani Yun-Kai Zhang Yi-Jun Wang Kamlesh Sodani Amal Kaddoumi Charles R. Ashby Zhe-Sheng Chen

Paclitaxel exhibits clinical activity against a wide variety of solid tumors. However, resistance to paclitaxel significantly attenuates the response to chemotherapy. The ABC transporter subfamily C member 10 (ABCC10), also known as multi-drug resistance protein 7 (MRP7) efflux transporter, is a major mediator of paclitaxel resistance. Here, we determine the effect of NVP-BHG712, a specific Eph...

Journal: :Therapeutics and Clinical Risk Management 2005
Charity D Scripture William D Figg Alex Sparreboom

Paclitaxel is an anticancer agent effective for the treatment of breast, ovarian, lung, and head and neck cancer. Because of water insolubility, paclitaxel is formulated with the micelle-forming vehicle Cremophor EL to enhance drug solubility. However, the addition of Cremophor EL results in hypersensitivity reactions, neurotoxicity, and altered pharmacokinetics of paclitaxel. To circumvent the...

Journal: :Brazilian Journal of Pharmaceutical Sciences 2023

Paclitaxel (PTX) is one of the most effective drugs used in treatment breast cancer. Nonetheless, appearance MDR1 (multidrug resistance 1) tumor cells has become a significant hindrance for efficacious chemotherapy. In this study, we show that expression level Egr-1 (early growth response gene-1) cancer tissues (from paclitaxel chemotherapy failure patients) and MCF-7/PTX (the cell line was res...

Journal: :Annals of nuclear medicine 1999
T Inoue C Li D J Yang T Higuchi N Oriuchi D Yu L Milas N Hunter S Wallace E E Kim D A Podoloff

UNLABELLED Our goal was to determine whether scintigraphy with 111In-DTPA-paclitaxel could predict the response to chemotherapy with paclitaxel. METHODS Ovarian carcinoma (OCA 1), mammary carcinoma (MCA-4), fibrosarcoma (FSA) and squamous cell carcinoma (SCC VII) were inoculated into the thighs of female C3Hf/Kam mice. Mice bearing 8 mm tumors were treated with paclitaxel (40 mg/kg). The grow...

2014
Neha Gupta Hassan Hatoum Grace K Dy

Lung cancer is the leading cause of cancer mortality worldwide in both men and women. Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for more than 80% of cases. Paclitaxel has a broad spectrum of activity against various malignancies, including NSCLC. Paclitaxel is poorly soluble in water and thus, until recently, its commercially available preparations co...

Journal: :The Journal of clinical investigation 2002
Stephan Fellner Björn Bauer David S Miller Martina Schaffrik Martina Fankhänel Thilo Spruss Günther Bernhardt Claudia Graeff Lothar Färber Harald Gschaidmeier Armin Buschauer Gert Fricker

Paclitaxel concentrations in the brain are very low after intravenous injection. Since paclitaxel is excluded from some tumors by p-glycoprotein (p-gp), the same mechanism may prevent entry into the brain. In vitro, paclitaxel transport was examined in capillaries from rat brains by confocal microscopy using BODIPY Fl-paclitaxel. Western blots and immunostaining demonstrated apical expression o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید